Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TargetGene Biotechnologies
Rehovot, HaMerkaz, Israel
- Ownership
- Private
- Development stage
- Other
01
Overview
TargetGene Biotechnologies is a privately held Israeli gene-editing company developing its proprietary TGEE/T-GEE genome-editing platform for therapeutic genome engineering and advanced cell line development, with a main focus on pre-clinical applications in cancer, immune disorders, and other genetic diseases; specific lead therapeutic programs and clinical results have not been publicly disclosed yet.[1][2]
- Therapeutic areas
- OncologyImmunologyRare Diseases
- Modalities
- Gene therapyCRISPR-based therapyGuide RNA therapy
- Industry
- Biotech
02
Partnerships
Kadimastem – strategic collaboration to combine TargetGene’s TGEE gene-editing platform with Kadimastem’s cell therapy platforms (AstroRx for amyotrophic lateral sclerosis and IsletRx for diabetes) to develop next-generation gene-edited cell therapies, expected to continue under the combined company NewCelX after the proposed NLS Pharmaceutics–Kadimastem merger.[2]
Beyond the preview
Go deeper on TargetGene Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TargetGene Biotechnologies.